58 related articles for article (PubMed ID: 9066705)
21. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
22. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
[TBL] [Abstract][Full Text] [Related]
23. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
24. Adenoid basal carcinoma of the uterine cervix: detection of integrated human papillomavirus in a rare tumor of putative "reserve cell" origin.
Grayson W; Taylor LF; Cooper K
Int J Gynecol Pathol; 1997 Oct; 16(4):307-12. PubMed ID: 9421068
[TBL] [Abstract][Full Text] [Related]
25. Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer.
Sobti RC; Parashar K; Kaur R; Capalash N
J Environ Pathol Toxicol Oncol; 2002; 21(1):79-85. PubMed ID: 11934017
[TBL] [Abstract][Full Text] [Related]
26. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
28. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
[TBL] [Abstract][Full Text] [Related]
29. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 and coexistence of HPV in premalignant lesions and in cervical cancer.
Markowska J; Nowak M; Bar M; Harlozinska A
Eur J Gynaecol Oncol; 1995; 16(5):368-72. PubMed ID: 8549602
[TBL] [Abstract][Full Text] [Related]
31. In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells.
Heiles HB; Genersch E; Kessler C; Neumann R; Eggers HJ
Biotechniques; 1988; 6(10):978-81. PubMed ID: 2856200
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of p53 protein in anogenital lesions and its relationship with HPV status.
Caruso ML; Valentini AM
Anticancer Res; 1998; 18(6A):4097-100. PubMed ID: 9891451
[TBL] [Abstract][Full Text] [Related]
33. The role of p53 and HPV in cervical cancer.
Street D; Delgado G
Gynecol Oncol; 1995 Sep; 58(3):287-8. PubMed ID: 7672693
[No Abstract] [Full Text] [Related]
34. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type.
Herrington CS; Graham D; Southern SA; Bramdev A; Chetty R
Hum Pathol; 1999 Aug; 30(8):906-10. PubMed ID: 10452502
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostics of human papillomaviruses].
Mikysková I; Michal M
Ceska Gynekol; 2004 Nov; 69(6):510-6. PubMed ID: 15633425
[TBL] [Abstract][Full Text] [Related]
36. Human papillomaviruses, p53, and cervical neoplasia.
Lane S; Wells M
J Pathol; 1994 Apr; 172(4):299-300. PubMed ID: 8207608
[No Abstract] [Full Text] [Related]
37. Viruses and cancer, with particular focus on human papillomaviruses in neoplastic lesions of the cervix uteri.
Chow VT; Tham KM; Bernard HU
Ann Acad Med Singap; 1990 Mar; 19(2):208-18. PubMed ID: 2161193
[TBL] [Abstract][Full Text] [Related]
38. Nonisotopic in situ hybridization in the detection of integrated HPV 16/18 in cervical cancers.
Cooper K
Hum Pathol; 1996 Jul; 27(7):745. PubMed ID: 8698324
[No Abstract] [Full Text] [Related]
39. p53 in human papillomavirus associated anogenital cancers.
Cooper K
J Clin Pathol; 1995 Apr; 48(4):393. PubMed ID: 7615867
[No Abstract] [Full Text] [Related]
40. An unusual cervical carcinoma showing exception to epitheliotropism of human papillomavirus.
Grayson W; Cooper K
Hum Pathol; 1999 Nov; 30(11):1397. PubMed ID: 10571525
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
